TransMedics Group, Inc.
US ˙ NasdaqGM ˙ US89377M1099

SecurityTMDX / TransMedics Group, Inc.
InstitutionRoyce Value Trust Inc
Latest Disclosed Ownership127,500 shares
Latest Disclosed Value $ 17,086,275
Royce Value Trust Inc reports 15.00% decrease in ownership of TMDX / TransMedics Group, Inc.

On August 15, 2025 - Royce Value Trust Inc filed a NPORT-P form disclosing ownership of 127,500 shares of TransMedics Group, Inc. (US:TMDX) valued at $17,086,275 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 19, 2025 disclosing 150,000 shares of TransMedics Group, Inc.. This represents a change in shares of -15.00% during the quarter. The current value of the position is $8,845,312 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-15 2025-06-30 NP TransMedics Group EC US89377M1099 127,500 -22,500 -15.00 17,086 69.30 0.8530
2025-05-19 2025-03-31 NP TransMedics Group EC US89377M1099 150,000 0 0.00 10,092 7.91 0.5484
2025-02-21 2024-12-31 NP TransMedics Group EC US89377M1099 150,000 0 0.00 9,352 -60.29 0.4680
2024-11-19 2024-09-30 NP TransMedics Group EC US89377M1099 150,000 0 0.00 23,550 4.24 1.1656
2024-08-12 2024-06-30 NP TransMedics Group EC US89377M1099 150,000 0 0.00 22,593 103.71 1.1842
2024-05-28 2024-03-31 NP TransMedics Group EC US89377M1099 150,000 -10,500 -6.54 11,091 -12.45 0.5669
2024-02-20 2023-12-31 NP TransMedics Group EC US89377M1099 160,500 105,000 189.19 12,668 316.98 0.6796
2023-11-22 2023-09-30 NP TransMedics Group EC US89377M1099 55,500 -4,000 -6.72 3,039 -39.19 0.1827
2023-08-09 2023-06-30 NP TransMedics Group EC US89377M1099 59,500 -1,000 -1.65 4,997 9.06 0.2850
2023-05-19 2023-03-31 NP TransMedics Group EC US89377M1099 60,500 -500 -0.82 4,582 21.71 0.2715
2023-02-21 2022-12-31 NP TransMedics Group EC US89377M1099 61,000 50,000 454.55 3,765 720.04 0.2345
2022-11-17 2022-09-30 NP TransMedics Group EC US89377M1099 11,000 0 0.00 459 33.04 0.0311
2022-08-16 2022-06-30 NP TransMedics Group EC US89377M1099 11,000 11,000 346 0.0219
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.